AI
DRTX

Analytic Investors’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Analytic Investors’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-32,563
Closed -$555K – 715
2014
Q2 		$555K Buy
+32,563
New +$485K 0.01% 400

Other funds holding DRTX

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Analytic Investors's DRTX Position: Q3 2014 in Review

Analytic Investors sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q3 2014, closing a stake of 32,563 shares — an estimated $555K sold.

Analytic Investors first reported a position in DRTX in Q2 2014 and held it in 1 quarter. The position peaked at $555K in Q2 2014. 70 funds tracked by Wall St. Rank hold DRTX as of Q3 2014.

  • Analytic Investors reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Analytic Investors sold 32,563 DURATA THERAPEUTICS INC COM STK (DE) shares in Q3 2014, an estimated $555K.
  • Analytic Investors first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Analytic Investors's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $555K in Q2 2014.
  • 70 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q3 2014.

Based on Analytic Investors's 13F filing for Q3 2014, filed 7 Nov 2014.